Clinical Trial Update: A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease. [Phase 2]

View source ↗

Summary

Sanofi is conducting a Phase 2 trial to evaluate the efficacy and safety of SAR441566 in Crohn's disease. Recruitment is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• SAR441566 (SAR441566)

Snippet

Sponsor: Sanofi | Conditions: Crohn's Disease | Phase 2 | Status: RECRUITING